leisure time -WSS

leisure time

author：entertainment 2025-10-01 13:59:34 - browse：229

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： PEPFAR is under serious threat — and so is global health

explore

WSS

Food makers tried to stack nutrition panel with preferred experts

FDA proposes changes to key medical devices approval pathway

New Covid vaccine is recommended for everyone 6 months or older

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Pope Francis asks Church to identify 21st

White House touts steps to stem shortages of cancer treatments

knowledge

leisure time

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

IRA could hurt research into orphan drugs for rare diseases

Guidelines to prevent youth baseball injuries need more muscle

2 million sign

23andMe had bad news about my health. I wish a person had delivered it

Former New York Mayor de Blasio and wife announce separation, but not divorce

Hollywood unions extend contract negotiations for actors

2 million sign

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A bus careens into a gulch in southern Mexico, leaving 27 people dead

hotspot

Will the IRA bring competition to the biologics market?

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

PEPFAR is under serious threat — and so is global health

Popular nasal decongestant doesn't actually relieve congestion

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Israel withdraws forces after 2

explore

Wikipedia

explore

entertainment